Mbx Biosciences

(NASDAQ) MBX

Current Price$32.46

Market Cap$1.54B

Since IPO (2024)+37%

5 YearN/A

1 Year+205%

1 Month-2%

Mbx Biosciences Financials at a Glance

Market Cap

$1.54B

Revenue (TTM)

$0.00

Net Income (TTM)

$86.61M

EPS (TTM)

$-2.21

P/E Ratio

-14.69

Dividend

$0.00

Beta (Volatility)

1.62 (High)

Dividend

$0.00

Beta (Volatility)

1.62 (High)

Price

$32.46

Volume

606,377.078

Open

$34.87

Price

$32.46

Volume

606,377.078

Open

$34.87

Previous Close

$32.45

Daily Range

$32.00 - $35.27

52-Week Range

$9.43 - $45.85

Dividend

$0.00

Beta (Volatility)

1.62 (High)

Price

$32.46

Volume

606,377.078

Open

$34.87

Previous Close

$32.45

Daily Range

$32.00 - $35.27

52-Week Range

$9.43 - $45.85

MBX News

Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase

Cory RenauerApr 22, 2026

MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know

Jonathan PoncianoMar 26, 2026

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones

Jonathan PoncianoDec 3, 2025

Mbx Biosciences (MBX) Q2 Loss Widens 22%

Motley Fool Markets TeamAug 7, 2025

MBX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mbx Biosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Peter Kent Hawryluk, MBA

Website

www.mbxbio.com

Headquarters

Carmel, IN 46032, US

MBX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-26%

Return on Capital

-23%

Return on Assets

-19%

Earnings Yield

-6.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.54B

Shares Outstanding

47.60M

Volume

606.38K

Avg. Volume

573.14K

Financials (TTM)

Gross Profit

$248.00K

Operating Income

$98.06M

EBITDA

$98.06M

Operating Cash Flow

$79.95M

Capital Expenditure

$1.93M

Free Cash Flow

$81.88M

Cash & ST Invst.

$373.70M

Total Debt

$596.00K

Mbx Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$64.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.54B

N/A

Market Cap/Employee

$35.92M

N/A

Employees

N/A

Net Income

$23.52M

+1.5%

EBITDA

$27.27M

-3.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$439.42M

+82.6%

Accounts Receivable

$3.16M

+127.9%

Inventory

$0.00

N/A

Long Term Debt

$377.00K

N/A

Short Term Debt

$178.00K

+36.9%

Return on Assets

-19.13%

N/A

Return on Invested Capital

-22.55%

N/A

Free Cash Flow

$20.64M

+9.1%

Operating Cash Flow

$20.21M

+10.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVBPArriVent BioPharma, Inc. Common Stock

AVBPArriVent BioPharma, Inc. Common Stock$27.87-1.94%

MLTXMoonLake Immunotherapeutics

MLTXMoonLake Immunotherapeutics$17.55-4.57%

IOVAIovance Biotherapeutics, Inc.

IOVAIovance Biotherapeutics, Inc.$3.45-1.99%

MGTXMeiraGTx Holdings plc

MGTXMeiraGTx Holdings plc$9.40-5.53%

DNAGinkgo Bioworks Holdings, Inc.

DNAGinkgo Bioworks Holdings, Inc.$7.71-1.78%

REPLReplimune Group, Inc.

REPLReplimune Group, Inc.$5.22+5.88%

VSTMVerastem, Inc.

VSTMVerastem, Inc.$4.32-8.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About MBX

What is the current price of Mbx Biosciences?

Mbx Biosciences is trading at $32.45 per share.

What is the 52-week range for Mbx Biosciences?

Over the past 52 weeks, Mbx Biosciences has traded between $9.43 and $45.85.

How much debt does Mbx Biosciences have?

As of the most recent reporting period, Mbx Biosciences reported total debt of $556,000.

How much cash does Mbx Biosciences have on hand?

Mbx Biosciences reported $45.21M in cash and cash equivalents in its most recent financial results.

What is Mbx Biosciences’s dividend yield?

Mbx Biosciences does not currently have a dividend yield.

Mbx Biosciences

Mbx Biosciences Financials at a Glance

MBX News

Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase

MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones

Mbx Biosciences (MBX) Q2 Loss Widens 22%

MBX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mbx Biosciences

MBX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mbx Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MBX

What is the current price of Mbx Biosciences?

What is the 52-week range for Mbx Biosciences?

How much debt does Mbx Biosciences have?

How much cash does Mbx Biosciences have on hand?

What is Mbx Biosciences’s dividend yield?

Premium Investing Services